Recombinant Human TPD52 Protein，His

TPD52 (Tumor Protein D52) is a member of the tumor protein family, which is implicated in various cellular processes, including cell growth, differentiation, and apoptosis. Initial studies have suggested that TPD52 may play a significant role in oncogenesis and tumor progression, particularly in breast, prostate, and other types of cancers. The protein is believed to be involved in the regulation of cellular signaling pathways that affect cell proliferation and survival. As a result, TPD52 has garnered attention as a potential biomarker for cancer diagnosis and prognosis, as well as a target for therapeutic interventions. Research into the recombinant expression of TPD52 has been accelerated in recent years, enabling investigations into its structure and function. By producing TPD52 in a recombinant system, researchers can obtain large quantities of the protein for biochemical assays, structural studies, and functional analyses, crucial for elucidating its role in cancer biology. Furthermore, understanding the mechanisms by which TPD52 influences tumorigenesis could pave the way for the development of novel cancer treatments that specifically target this protein. Overall, TPD52 represents a promising area of research in cancer biology, with implications for diagnostic, prognostic, and therapeutic strategies in oncology.